STXS — Stereotaxis Inc
AMEX · Healthcare · Medical Instruments & Supplies
$1.40
+$0.02 (+1.82%)
Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX. It is led by David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., based in 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101, with about 131 employees. Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Latest reported STXS revenue for 2025-09-30 was $7.5M. Net income was -$6.5M. Revenue was down 15.2% from 2025-06-30 to 2025-09-30. STXS currently screens at market cap $174.0M.
Use this STXS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the STXS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the STXS SEC filings page. Lician reads the product cache first so this HTML stays unique to Stereotaxis Inc even when a live quote feed is slow.
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
STXS Key Statistics
Market Cap
$173.97M
Volume
170,191
Previous Close
$1.42
Day Range
$1.40 – $1.43
P/B Ratio
12.12
EPS
-$0.30
Revenue
$26.92M
Net Income
-$24.05M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+0.5%
Profit Margin
-89.3%
Employees
131
STXS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $26.92M | $26.77M | $28.15M | $35.02M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$24.05M | -$20.71M | -$18.29M | -$10.72M |
| EPS (Diluted) | -$0.30 | -$0.27 | -$0.26 | -$0.16 |
Total Assets
$46.72M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$12.22M
Operating Cash Flow
-$8.50M
Free Cash Flow
$0.00
Stereotaxis Inc Company Information
- CEO & Chairman
- David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
- Headquarters
- 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101
- Website
- www.stereotaxis.com
- Phone
- 314 678 6100
- IPO / Founded
- 2004-08-12
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies